MDG1:FRA
MediGene AG
€ 0.017
arrow_upward
+3.61%(+0.00060) 1D
6-р сарын 30, 22:00:00 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Barron's
·
9 минутын өмнө
Small-Cap Stocks Could Be Ready to Rebound
The Motley Fool
·
11 минутын өмнө
The U.S. Economy Just Delivered Bad News. History Says It Could Be Good News for the S&P 500.
TradingView
·
1 цагийн өмнө
Why Are Nasdaq Futures Surging Premarket? SPCX, ASTS, AAPL, TMUS, VZ, NVDA, MU, LITE Stocks In Focus
Yahoo Finance
·
2 цагийн өмнө
Scancell revs up for Nasdaq listing as cancer vaccine developer prepares phase III melanoma trial
Profile
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia